To advance innovation and our mission to help oncology patients, we collaborate with other industry-leading biotechnology, pharmaceutical, and emerging biotech companies.
Natasha Hernday
Chief Business Officer
In it for life, together
Our partnerships focus on:
Innovative in-licensing opportunities at all development stages to diversify and grow our emerging global portfolio
Clinical and research collaborations that broaden the potential of our internal programs
Novel platform technologies that synergize with or expand our antibody–drug conjugate (ADC) capabilities in new and unique ways
You are now leaving the Seagen site. Seagen does not necessarily endorse the organization associated with this link and takes no responsibility for the content contained therein. This resource link is for informational purposes only. Do you want to continue to the external site and leave Seagen.com?
You are now being directed to additional information from Seagen.